InflaRx (IFRX) said late Friday it received a deficiency notice from Nasdaq for failing to meet the minimum bid requirement of $1 per share for 30 consecutive trading days.
The company has until Jan. 7, 2026, to regain compliance.
The notice has no immediate effect on the listing or trading of InflaRx's shares, the company said, adding it plans to monitor the stock price and consider options to restore compliance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.